Gainers & Losers
Wed Jul 09 2025 07:15:31- Hindustan Unilever share price
- ₹2,429.101.51%
- Bajaj Finance share price
- ₹940.101.37%
- Mahindra And Mahindra share price
- ₹3,183.550.82%
- Bajaj Finserv share price
- ₹2,032.650.75%
- Itc share price
- ₹419.900.68%
Active Stocks
Wed Jul 09 2025 07:15:17- Gail India share price
- ₹186.45-3.22%
- Vedanta share price
- ₹434.30-4.80%
- Bharat Electronics share price
- ₹419.80-0.53%
- Tata Steel share price
- ₹158.00-2.44%
- Hdfc Bank share price
- ₹2,009.400.39%
Business News/Market/Market Stats/Emcure Pharmaceuticals share price/ Emcure Pharmaceuticals Balance Sheet Annual
Emcure Pharmaceuticals Balance Sheet Annual
1,246.90 +3.90 (0.31%)Updated : 09 Jul 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 8,232.72 | 7,806.16 | 6,672.53 | 6,063.47 |
| Cash Equivalents | 165.30 | 60.61 | 0.08 | 0.07 |
| Other Liabilities Total | 355.61 | 354.17 | 105.47 | 113.32 |
| Long Term Debt | 189.94 | 761.92 | 737.18 | 707.76 |
| Common Stock Total | 189.48 | 181.15 | 180.85 | 180.85 |
| Other Current Assets Total | 327.95 | 9.65 | 7.46 | 7.65 |
| Total Assets | 8,232.72 | 7,806.16 | 6,672.53 | 6,063.47 |
| Current Portof LT Debt/ Capital Leases | 575.50 | 390.66 | 329.66 | 297.68 |
| Total Equity | 4,446.19 | 2,952.28 | 2,501.13 | 1,987.55 |
| Long Term Investments | 58.81 | 19.99 | 58.15 | 46.13 |
| Retained Earnings( Accumulated Deficit) | 4,256.70 | 2,712.52 | 2,293.77 | 1,791.03 |
| Total Common Shares Outstanding | 18.95 | 18.91 | 18.91 | 18.91 |
| Property/ Plant/ Equipment Total- Gross | 124.06 | 3,704.79 | 3,319.44 | 2,917.04 |
| Tangible Book Valueper Share Common Eq | 184.67 | 109.25 | 114.10 | 85.08 |
| Goodwill Net | 367.78 | 378.69 | 217.74 | 217.39 |
| Total Liabilities | 3,786.54 | 4,853.88 | 4,171.41 | 4,075.92 |
| Total Debt | 1,022.75 | 2,334.97 | 2,334.30 | 2,217.20 |
| Short Term Investments | 128.56 | 348.39 | 204.48 | 145.54 |
| Cashand Short Term Investments | 293.86 | 517.39 | 446.83 | 308.39 |
| Total Receivables Net | 2,002.24 | 2,113.34 | 1,902.43 | 1,515.74 |
| Deferred Income Tax | 120.03 | 137.42 | 38.89 | 42.61 |
| Accounts Receivable- Trade Net | 2,002.24 | 1,873.48 | 1,659.73 | 1,313.41 |
| Property/ Plant/ Equipment Total- Net | 2,427.12 | 2,397.21 | 2,214.76 | 1,985.46 |
| Minority Interest | 195.37 | 169.48 | 148.53 | 126.59 |
| Total Current Liabilities | 2,668.27 | 3,210.47 | 3,019.19 | 2,964.83 |
| Total Inventory | 1,931.81 | 1,525.10 | 1,383.03 | 1,449.42 |
| Accounts Payable | 1,479.58 | 1,309.37 | 1,086.11 | 1,125.19 |
| Other Currentliabilities Total | 613.19 | 355.41 | 284.41 | 295.21 |
| Total Long Term Debt | 447.25 | 982.34 | 859.31 | 828.56 |
| Intangibles Net | 579.23 | 507.77 | 125.81 | 161.36 |
| Other Long Term Assets Total | 149.88 | 138.07 | 136.76 | 143.80 |
| Note Receivable- Long Term | 94.04 | 104.53 | 83.41 | 85.23 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 4,555.86 | 4,259.92 | 3,835.91 | 3,424.10 |
| Capital Lease Obligations | 257.32 | 220.42 | 122.14 | 120.80 |
| Accumulated Depreciation Total | - | -1,307.58 | -1,104.69 | -931.58 |
| Accrued Expenses | - | 193.07 | 173.69 | 155.79 |
| Other Equity Total | - | 48.73 | 26.50 | 15.67 |
| Prepaid Expenses | - | 94.44 | 96.17 | 142.90 |
| Additional Paid- In Capital | - | 9.88 | - | - |
| Cash | - | 108.40 | 242.27 | 162.78 |
| Notes Payable/ Short Term Debt | - | 961.98 | 1,145.33 | 1,090.96 |
*All figures in crores except per share values
Emcure Pharmaceuticals Quick Links
Emcure Pharmaceuticals Dividend Emcure Pharmaceuticals Bonus Emcure Pharmaceuticals News Emcure Pharmaceuticals AGM Emcure Pharmaceuticals Rights Emcure Pharmaceuticals Splits Emcure Pharmaceuticals Board Meetings Emcure Pharmaceuticals Key Metrics Emcure Pharmaceuticals Shareholdings Emcure Pharmaceuticals Profit Loss Emcure Pharmaceuticals Cashflow Emcure Pharmaceuticals Q1 Results Emcure Pharmaceuticals Q2 Results Emcure Pharmaceuticals Q3 Results Emcure Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,429.10+36.10(1.51%)
940.10+12.70(1.37%)
3,183.55+26.00(0.82%)
158.00-3.95 (-2.44%)
1,678.50-30.20 (-1.77%)